Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¿¡ ¹ß»ýÇÑ ³¶Æ÷¼º °úºÐºñ¼º °ü»óÇÇ¾Ï 1¿¹ Case of a Cystic Hypersecretory Duct Carcinoma of the Breast

´ëÇÑ¿Ü°úÇÐȸÁö 2002³â 63±Ç 3È£ p.247 ~ 251
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ»óö/Sang Chul Lee ±è±âȯ/¾ÈâÇõ/¹Ú¿ìÂù/¿À¼¼Á¤/±èÁ¤¼ö/ÀüÇظí/À¯½ÂÁø/Á¤»ó¼³/ÀÓ±Ù¿ì/Kee Hwan Kim/Chang Hyeok Ahn/Woo Chan Park/Se Jung Oh/Jeong Soo Kim/Hae Myung Jeon/Seung Jin Yoo/Sang Seul Jung/Keun Woo Lim

Abstract


Breast cystic hypersecretory duct carcinomas (CHDC), characterized by cystic dilatation of ducts, cysts filled with thyroid colloid-like eosinophilic material, and by micropapillary carcinomas in the epithelium lining the cyst, is a rare
histological
variant of intraductal carcinomas. CHDC is differentiated from cystic hypersecretory hyperplasia. It's clinical manifestations are similar to those of other intraductal carcinomas. CHDC has a low-grade behavior for many years, but can be invasive,
with
the potential for metastasis. The importance of CHDC is its differentiation from a variety of other lesions of the breast, both benign and malignant. Various differential diagnoses for CHDC include: fibrocystic changes of the breast with
microcyst
formation, juvenile papillomatosis, benign mucocele-like lesions, juvenile secretory carcinomas, mucin-producing colloid carcinomas and metastatic follicular thyroid carcinomas. Histochemical staining (PAS, alcian blue & mucicarmine) or
immunoperoxidase
studies (CEA, alpha-lactalbumin and thyroglobulin) may also helpful in differential diagnoses. We report a case of a cystic hypersecretory duct carcinoma (CHDC) of the breast, and present a review of the literature.

Å°¿öµå

À¯¹æ¾Ï; °úºÐºñ¼º; ³¶Æ÷¼º; Breast cancer; Hypersecretory; Cystic;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS